Amedisys, Inc. (AMED) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Amedisys, Inc. (AMED) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Die Aktie erzielt 50/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 16. März 2026Amedisys, Inc. (AMED) Gesundheitswesen & Pipeline-Uebersicht
Amedisys, Inc. is a healthcare provider specializing in home health, hospice, personal care, and high acuity services across 38 states and the District of Columbia. With a market capitalization of $3.32 billion and a P/E ratio of 22.16, Amedisys addresses the growing demand for in-home healthcare solutions.
Investmentthese
Amedisys presents a compelling investment case based on its established market presence and diversified service offerings within the growing home healthcare sector. The company's focus on home health and hospice care aligns with the increasing demand for cost-effective and patient-centric healthcare solutions. With a market capitalization of $3.32 billion and a profit margin of 6.2%, Amedisys demonstrates financial stability. Growth catalysts include expanding its high acuity care services and leveraging its existing infrastructure to penetrate new geographic markets. Potential risks include regulatory changes and increased competition from other home healthcare providers. The company's beta of 0.90 suggests moderate volatility relative to the market.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $3.32 billion indicates a strong market valuation.
- P/E ratio of 22.16 suggests a moderate valuation relative to earnings.
- Profit margin of 6.2% reflects profitability within the healthcare services sector.
- Gross margin of 52.3% demonstrates efficient cost management.
- Presence in 38 states and the District of Columbia provides a broad geographic footprint.
Wettbewerber & Vergleichsunternehmen
Staerken
- Diversified service offerings across home health, hospice, personal care, and high acuity care.
- Extensive network of care centers and healthcare professionals.
- Established relationships with hospitals and healthcare systems.
- Strong brand reputation and market presence.
Schwaechen
- Exposure to regulatory changes and reimbursement pressures.
- Competition from other home healthcare providers.
- Dependence on government funding and reimbursement policies.
- Potential for staffing shortages and labor cost increases.
Katalysatoren
- Ongoing: Expansion of high acuity care services to meet the growing demand for hospital-at-home models.
- Ongoing: Geographic expansion into underserved markets.
- Ongoing: Strategic acquisitions to expand service offerings and market reach.
- Ongoing: Leveraging technology to improve operational efficiency and enhance patient care.
Risiken
- Potential: Changes in government regulations and reimbursement policies.
- Ongoing: Increased competition from other home healthcare providers.
- Potential: Economic downturns and reduced healthcare spending.
- Potential: Cybersecurity threats and data breaches.
Wachstumschancen
- Growth opportunity 1: Expansion of High Acuity Care Services: Amedisys can capitalize on the increasing demand for hospital-at-home models by expanding its High Acuity Care segment. This involves delivering acute medical care in patients' homes, reducing the need for hospital stays and lowering healthcare costs. The market for hospital-at-home services is projected to reach billions of dollars in the coming years, presenting a significant growth opportunity for Amedisys. Timeline: Ongoing.
- Growth opportunity 2: Geographic Expansion: Amedisys can expand its presence in underserved markets by establishing new care centers and acquiring existing providers. This involves identifying regions with a high demand for home health, hospice, and personal care services and developing a strategic plan for market entry. Geographic expansion can drive revenue growth and increase Amedisys's market share. Timeline: Ongoing.
- Growth opportunity 3: Strategic Acquisitions: Amedisys can pursue strategic acquisitions to expand its service offerings and geographic reach. This involves identifying companies with complementary services or a strong presence in key markets and integrating them into Amedisys's operations. Strategic acquisitions can accelerate growth and enhance Amedisys's competitive position. Timeline: Ongoing.
- Growth opportunity 4: Technology Adoption: Amedisys can leverage technology to improve operational efficiency, enhance patient care, and reduce costs. This involves implementing telehealth solutions, remote monitoring devices, and data analytics tools to streamline workflows and improve patient outcomes. Technology adoption can drive innovation and create a competitive advantage for Amedisys. Timeline: Ongoing.
- Growth opportunity 5: Partnerships with Healthcare Systems: Amedisys can form partnerships with hospitals and healthcare systems to provide integrated care solutions. This involves collaborating with healthcare providers to deliver seamless transitions of care from hospitals to patients' homes, reducing hospital readmissions and improving patient satisfaction. Partnerships can drive referrals and increase Amedisys's patient volume. Timeline: Ongoing.
Chancen
- Expansion of high acuity care services to meet the growing demand for hospital-at-home models.
- Geographic expansion into underserved markets.
- Strategic acquisitions to expand service offerings and market reach.
- Leveraging technology to improve operational efficiency and enhance patient care.
Risiken
- Changes in government regulations and reimbursement policies.
- Increased competition from other home healthcare providers.
- Economic downturns and reduced healthcare spending.
- Cybersecurity threats and data breaches.
Wettbewerbsvorteile
- Established market presence and brand recognition.
- Extensive network of care centers and healthcare professionals.
- Diversified service offerings across home health, hospice, personal care, and high acuity care.
- Strong relationships with hospitals and healthcare systems.
Ueber AMED
Amedisys, Inc., founded in 1982 and headquartered in Baton Rouge, Louisiana, provides a range of healthcare services across the United States. The company operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment focuses on delivering skilled nursing, rehabilitation therapy, and social services to patients recovering from surgery, managing chronic conditions, or facing terminal illnesses. This segment aims to reduce hospital readmissions and improve patient outcomes through in-home care. The Hospice segment offers comfort and support to individuals dealing with terminal illnesses such as cancer, heart disease, pulmonary disease, and Alzheimer's. The Personal Care segment provides assistance with daily living activities, enabling patients to maintain independence and quality of life. The High Acuity Care segment delivers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, Amedisys owned and operated 331 home health care centers, 175 hospice care centers, 14 personal-care centers, and 8 high acuity care centers across 38 states and the District of Columbia. Amedisys's comprehensive service offerings and extensive geographic reach position it as a significant player in the evolving healthcare landscape.
Was das Unternehmen tut
- Provides home health services, including skilled nursing and rehabilitation therapy.
- Offers hospice care for patients with terminal illnesses.
- Delivers personal care services to assist with daily living activities.
- Provides high acuity care services, bringing hospital-level care to patients' homes.
- Operates a network of care centers across 38 states and the District of Columbia.
- Focuses on improving patient outcomes and reducing hospital readmissions.
Geschaeftsmodell
- Generates revenue through providing home health, hospice, personal care, and high acuity care services.
- Receives payments from Medicare, Medicaid, private insurance, and individual patients.
- Operates a network of care centers and employs healthcare professionals to deliver services.
- Focuses on managing costs and improving operational efficiency to maximize profitability.
Branchenkontext
Amedisys operates within the expanding medical care facilities industry, driven by an aging population and a growing preference for in-home healthcare services. The industry is characterized by increasing demand for home health, hospice, and personal care services. Key competitors include LHC Group (LHCG) and AccentCare, reflecting a fragmented market with opportunities for consolidation and expansion. The industry is subject to regulatory oversight and reimbursement policies, which impact revenue and profitability.
Wichtige Kunden
- Individuals recovering from surgery or managing chronic conditions.
- Patients with terminal illnesses requiring hospice care.
- Individuals needing assistance with daily living activities.
- Hospitals and healthcare systems seeking to reduce readmissions and improve patient outcomes.
Finanzdaten
Chart & Info
Amedisys, Inc. (AMED) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Stocks That Hit 52-Week Lows On Monday
benzinga · 10. Okt. 2022
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · 29. Sept. 2022
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · 14. Juni 2022
-
Stocks That Hit 52-Week Lows On Monday
· 23. Aug. 2021
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer AMED.
Kursziele
Wall-Street-Kurszielanalyse fuer AMED.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von AMED auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Wettbewerber & Vergleichsunternehmen
Fuehrung: Richard M. Ashworth
CEO
Richard M. Ashworth serves as the CEO of Amedisys, Inc. His career spans various leadership roles within the healthcare industry. Ashworth brings extensive experience in healthcare management, strategic planning, and operational execution. Prior to joining Amedisys, he held executive positions at leading healthcare organizations, where he focused on driving growth, improving patient outcomes, and enhancing operational efficiency. His expertise in healthcare delivery and business development positions him to lead Amedisys in a dynamic and competitive market.
Erfolgsbilanz: Under Richard M. Ashworth's leadership, Amedisys has focused on expanding its high acuity care services and leveraging technology to improve patient care. He has overseen strategic initiatives to enhance operational efficiency and drive revenue growth. Key milestones include expanding the company's geographic footprint and strengthening its relationships with hospitals and healthcare systems.
Was Anleger ueber Amedisys, Inc. (AMED) wissen wollen
What are the key factors to evaluate for AMED?
Amedisys, Inc. (AMED) currently holds an AI score of 50/100, indicating moderate score. Key strength: Diversified service offerings across home health, hospice, personal care, and high acuity care.. Primary risk to monitor: Potential: Changes in government regulations and reimbursement policies.. This is not financial advice.
How frequently does AMED data refresh on this page?
AMED prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AMED's recent stock price performance?
Recent price movement in Amedisys, Inc. (AMED) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified service offerings across home health, hospice, personal care, and high acuity care.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AMED overvalued or undervalued right now?
Determining whether Amedisys, Inc. (AMED) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AMED?
Before investing in Amedisys, Inc. (AMED), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding AMED to a portfolio?
Potential reasons to consider Amedisys, Inc. (AMED) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diversified service offerings across home health, hospice, personal care, and high acuity care.. Additionally: Extensive network of care centers and healthcare professionals.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of AMED?
Yes, most major brokerages offer fractional shares of Amedisys, Inc. (AMED) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track AMED's earnings and financial reports?
Amedisys, Inc. (AMED) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for AMED earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide additional insights.